The impact of TCF7L2 on aerobic glycolysis was further confirmed in vivo by assessing 18FDG uptake in pancreatic cancer patients and in a subcutaneous xenograft mouse model. The gene discussed is TCF7L2; the disease is familial pancreatic carcinoma.